LIVALO Side Effects

7027430-6 | Henoch-schonlein Purpura, Leukocytoclastic Vasculitis, Oedema Peripheral, Pyrexia
on Sep 17, 2010 Female patient from JAPAN , 35 years of age, weighting 101.2 lb, was diagnosed with hypercholesterolaemia, low density lipoprotein increased and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: henoch-schonlein purpura, leukocytoclastic vasculitis, oedema peripheral, pyrexia. Livalo dosage: 1 Mg; 1x; Po. During the same period patient was treated with CALONAL (View Calonal Review and Calonal Label ). Patient was hospitalized.

7027428-8 | Rhabdomyolysis
Patient was taking Livalo (View Usage). Patient had the following side effects: rhabdomyolysis on Sep 17, 2010 from JAPAN Additional patient health information: Male patient , 45 years of age, was diagnosed with hypercholesterolaemia and. Livalo dosage: 2 Mg; 1x; Po. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), SITAGLIPTIN PHOSPHATE HYDRATE (View Sitagliptin Phosphate Hydrate Review and Sitagliptin Phosphate Hydrate Label ), BLOPRESS (View Blopress Review and Blopress Label ), ARTIST (View Artist Review and Artist Label ), LIRAGLUTIDE (View Liraglutide Review and Liraglutide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

7027423-9 | Liver Disorder
Adverse event was reported on Sep 17, 2010 by a Male patient taking Livalo (View Usage) (Dosage: 2 Mg; 1x; Po) . Location: , 62 years of age, After Livalo was administered, patient had the following side effects: liver disorder.

7022282-2 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis
on Sep 13, 2010 Male patient from JAPAN , 82 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: anti-neutrophil cytoplasmic antibody positive vasculitis. Livalo dosage: 1 Mg;1x;po. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FURSULTIAMINE (View Fursultiamine Review and Fursultiamine Label ), TAURINE (View Taurine Review and Taurine Label ), EPADEL S (View Epadel-s Review and Epadel-s Label ), MAGMITT (View Magmitt Review and Magmitt Label ), CHINESE HERBAL MEDICINE (View Chinese Herbal Medicine Review and Chinese Herbal Medicine Label ). Patient was hospitalized.


7022276-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Sep 14, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Livalo dosage: 1 Mg;1x;po. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

7022226-3 | Abasia, Blood Creatine Phosphokinase Increased, Dizziness, Fall, Musculoskeletal Pain, Urinary Tract Infection
Patient was taking Livalo (View Usage). After Livalo was administered, patient had the following side effects: abasia, blood creatine phosphokinase increased, dizziness (What is dizziness?), fall (What is fall?), musculoskeletal pain, urinary tract infection (What is urinary tract infection?) on Sep 13, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, weighting 101.4 lb, was diagnosed with hypercholesterolaemia and. Livalo dosage: 1 Mg; 1x; Po. During the same period patient was treated with EPADEL S (View Epadel-s Review and Epadel-s Label ), BASEN (View Basen Review and Basen Label ), AMARYL (View Amaryl Review and Amaryl Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACTOS (View Actos Review and Actos Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

7007705-7 | Blood Creatine Phosphokinase Increased, Renal Failure Acute
Adverse event was reported on Sep 10, 2010 by a Male patient taking Livalo (View Usage) (Dosage: 1 Mg; 1x; Po) was diagnosed with dyslipidaemia, hyperlipidaemia and. Location: JAPAN , 57 years of age, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, renal failure acute. During the same period patient was treated with BEZAFIBRATE (BEZAFIBRATE) (200 Mg; Bid; Po) (View Bezafibrate (bezafibrate) Review and Bezafibrate (bezafibrate) Label ), ATELEC (View Atelec Review and Atelec Label ), GASLON N (View Gaslon N Review and Gaslon N Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), LIMAS (View Limas Review and Limas Label ), HIRNAMIN /00038601/ (View Hirnamin /00038601/ Review and Hirnamin /00038601/ Label ), ALTAT (View Altat Review and Altat Label ), AROTINOLOL HYDROCHLORIDE (View Arotinolol Hydrochloride Review and Arotinolol Hydrochloride Label ).

7003508-8 | Herpes Zoster, Neoplasm Skin, Presyncope
on Sep 02, 2010 Female patient from JAPAN , 84 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient had the following side effects: herpes zoster, neoplasm skin, presyncope. Livalo dosage: 2 Mg; 1x; Po. During the same period patient was treated with LANDEL (View Landel Review and Landel Label ), LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ). Patient was hospitalized.

7003491-5 | Lymphadenopathy, Metastases To Lymph Nodes
on Sep 02, 2010 Female patient from JAPAN , 70 years of age, weighting 127.9 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: lymphadenopathy, metastases to lymph nodes. Livalo dosage: 1 Mg; 1x; Po. During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ).

7003258-8 | Dizziness, Gastrointestinal Disorder, Hyperhidrosis, Nausea
Patient was taking Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), gastrointestinal disorder, hyperhidrosis, nausea (What is nausea?) on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Livalo dosage: 2 Mg; Po.

6988239-2 | Henoch-schonlein Purpura, Infection, Oedema Peripheral, Pyrexia
Adverse event was reported on Aug 31, 2010 by a Female patient taking Livalo (View Usage) (Dosage: 1 Mg; 1x; Po) was diagnosed with hypercholesterolaemia and. Location: JAPAN , 35 years of age, Patient had the following side effects: henoch-schonlein purpura, infection (What is infection?), oedema peripheral, pyrexia. During the same period patient was treated with CALONAL (View Calonal Review and Calonal Label ). Patient was hospitalized.

6988234-3 | Gastric Cancer, Large Intestine Carcinoma
on Sep 02, 2010 Male patient from JAPAN , 63 years of age, weighting 147.7 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: gastric cancer, large intestine carcinoma. Livalo dosage: 2 Mg; 1x; Po. During the same period patient was treated with NOVOMIX 30 /03581901/ (View Novomix 30 /03581901/ Review and Novomix 30 /03581901/ Label ). Patient was hospitalized.

6987800-9 | Blood Glucose Increased, Tremor
on Aug 02, 2010 Male patient from UNITED STATES , 62 years of age, weighting 240.3 lb, was diagnosed with dyslipidaemia and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, tremor. Livalo dosage: 0.5 Df;1x;po. During the same period patient was treated with FINASTERIDE (View Finasteride Review and Finasteride Label ), STEROID (View Steroid Review and Steroid Label ).

6987798-3 | Dizziness, Nausea
Patient was taking Livalo (View Usage). Patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?) on Jul 29, 2010 from UNITED STATES Additional patient health information: Female patient , 78 years of age, weighting 172.0 lb, was diagnosed with hypercholesterolaemia and. Livalo dosage: 4 Mg;1x;po. During the same period patient was treated with MACROBID /00984601/ (View Macrobid /00984601/ Review and Macrobid /00984601/ Label ), LIVER TONIC (View Liver Tonic Review and Liver Tonic Label ), TENORMIN (View Tenormin Review and Tenormin Label ), NORVASC (View Norvasc Review and Norvasc Label ), XANAX (View Xanax Review and Xanax Label ), KLOR CON/25 (View Klor-con/25 Review and Klor-con/25 Label ).

6987796-X | Fatigue
Adverse event was reported on Jul 21, 2010 by a Female patient taking Livalo (View Usage) (Dosage: ) . Location: UNITED STATES , 50 years of age, After Livalo was administered, patient had the following side effects: fatigue.

6987767-3 | Oedema Peripheral
on Jul 15, 2010 Female patient from UNITED STATES , 59 years of age, was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Livalo dosage: 2 Mg;po ; 2 Mg;po.

6986131-0 | Duodenal Ulcer Haemorrhage, Fall, Femur Fracture, Joint Arthroplasty
on Aug 26, 2010 Female patient from JAPAN , 75 years of age, weighting 124.6 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient had the following side effects: duodenal ulcer haemorrhage, fall (What is fall?), femur fracture, joint arthroplasty. Livalo dosage: 1 Mg;1x;po. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), DIOVAN /01319601/ (View Diovan /01319601/ Review and Diovan /01319601/ Label ), AMARYL (View Amaryl Review and Amaryl Label ), MELBIN /00082702/ (View Melbin /00082702/ Review and Melbin /00082702/ Label ), OLMETEC (View Olmetec Review and Olmetec Label ). Patient was hospitalized.

6975676-5 | Biliary Dyskinesia, Cholecystectomy, Hepatobiliary Scan Abnormal, Hepatosplenomegaly
Patient was taking Livalo (View Usage). After Livalo was administered, patient had the following side effects: biliary dyskinesia, cholecystectomy, hepatobiliary scan abnormal, hepatosplenomegaly on Aug 24, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 405.7 lb, . Livalo dosage: 2 Mg; Po. During the same period patient was treated with CHANTIX (1 Mg; Bid;) (View Chantix Review and Chantix Label ). Patient was hospitalized.

6963821-7 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis, Arthralgia, Haematuria, Nephrosclerosis, Proteinuria, Pyrexia, Tubulointerstitial Nephritis, White Blood Cell Count Increased
Adverse event was reported on Aug 25, 2010 by a Male patient taking Livalo (View Usage) (Dosage: 1 Mg;1x;po) was diagnosed with hypercholesterolaemia and. Location: JAPAN , 82 years of age, Patient experienced the following unwanted or unexpected effects: anti-neutrophil cytoplasmic antibody positive vasculitis, arthralgia, haematuria, nephrosclerosis, proteinuria, pyrexia, tubulointerstitial nephritis, white blood cell count increased. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), FUMARATE (View Fumarate Review and Fumarate Label ), FURSULTIAMINE (View Fursultiamine Review and Fursultiamine Label ), TAURINE (View Taurine Review and Taurine Label ), EPADEL S (View Epadel-s Review and Epadel-s Label ), MAGMITT (View Magmitt Review and Magmitt Label ), CHINESE HERBAL MEDICINE (View Chinese Herbal Medicine Review and Chinese Herbal Medicine Label ). Patient was hospitalized.

6940289-8 | Asthma
on Aug 16, 2010 Male patient from JAPAN , 79 years of age, weighting 180.8 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient had the following side effects: asthma (What is asthma?). Livalo dosage: 2 Mg;1x;po, 2 Mg;1x;po. During the same period patient was treated with BEZATOR (View Bezator Review and Bezator Label ), ADALAT (View Adalat Review and Adalat Label ), ACTOS (View Actos Review and Actos Label ), MAINTATE (View Maintate Review and Maintate Label ), TANATRIL (View Tanatril Review and Tanatril Label ). Patient was hospitalized.

6940261-8 | Blood Creatinine Increased, Haemodialysis
on Aug 05, 2010 Female patient from JAPAN , 78 years of age, weighting 123.9 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: blood creatinine increased, haemodialysis. Livalo dosage: 2 Mg;1x;po, 2 Mg;1x;po. During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ), CONIEL (View Coniel Review and Coniel Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ).

6940109-1 | Abdominal Pain, Hydronephrosis, Pyrexia, Vomiting
Patient was taking Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), hydronephrosis, pyrexia, vomiting on Aug 05, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, weighting 149.9 lb, was diagnosed with hypercholesterolaemia and. Livalo dosage: 2 Mg 1x Po. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), MICARDIS (View Micardis Review and Micardis Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), PENFILL 30R (View Penfill 30r Review and Penfill 30r Label ), MELBIN /00082702/ (View Melbin /00082702/ Review and Melbin /00082702/ Label ), BLOPRESS (View Blopress Review and Blopress Label ). Patient was hospitalized.

6940091-7 | Mean Cell Volume Decreased, Red Blood Cell Count Decreased
Adverse event was reported on Aug 05, 2010 by a Female patient taking Livalo (View Usage) (Dosage: 2 Mg 1x Po) was diagnosed with hypercholesterolaemia and. Location: JAPAN , 88 years of age, weighting 108.0 lb, Patient had the following side effects: mean cell volume decreased, red blood cell count decreased. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), BALOTEIN (View Balotein Review and Balotein Label ), VASOMET (View Vasomet Review and Vasomet Label ), AVAPRO (View Avapro Review and Avapro Label ).

6937109-4 | Blood Glucose Increased, Decreased Appetite, Depressed Level Of Consciousness, Upper Respiratory Tract Inflammation
on Aug 05, 2010 Female patient from JAPAN , 61 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: blood glucose increased, decreased appetite, depressed level of consciousness, upper respiratory tract inflammation. Livalo dosage: 2 Mg;1x;po; 2 Mg;1x;po. During the same period patient was treated with BLOPRESS (CON.) (View Blopress (con.) Review and Blopress (con.) Label ), CALBLOCK (CON.) (View Calblock (con.) Review and Calblock (con.) Label ), LASIX /00032601/(CON.) (View Lasix /00032601/(con.) Review and Lasix /00032601/(con.) Label ), AMARYL (CON.) (View Amaryl (con.) Review and Amaryl (con.) Label ), NOVORAPID (CON.) (View Novorapid (con.) Review and Novorapid (con.) Label ), LANTUS (CON.) (View Lantus (con.) Review and Lantus (con.) Label ). Patient was hospitalized.

6937099-4 | Blood Creatine Phosphokinase Increased, Dizziness, Fall, Pyrexia
on Aug 05, 2010 Male patient from JAPAN , 65 years of age, weighting 110.2 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, dizziness (What is dizziness?), fall (What is fall?), pyrexia. Livalo dosage: 1 Mg;1x;po; 1 Mg;1x;po. During the same period patient was treated with EPADEL S (CON.) (View Epadel-s (con.) Review and Epadel-s (con.) Label ), BASEN (CON.) (View Basen (con.) Review and Basen (con.) Label ), AMARYL (CON.) (View Amaryl (con.) Review and Amaryl (con.) Label ), MEDET (CON.) (View Medet (con.) Review and Medet (con.) Label ), ACTOS /01460202/ (CON.) (View Actos /01460202/ (con.) Review and Actos /01460202/ (con.) Label ). Patient was hospitalized.

6933588-7 | Gallbladder Cancer
Patient was taking Livalo (View Usage). Patient had the following side effects: gallbladder cancer (What is gallbladder cancer?) on Aug 05, 2010 from JAPAN Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with hypercholesterolaemia and. Livalo dosage: 1 Mg;1x;po, 1 Mg;1x;po. During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ).

6905969-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Rheumatoid Factor Increased
Adverse event was reported on Jul 15, 2010 by a Male patient taking Livalo (View Usage) (Dosage: 2 Mg; 1x; Po) was diagnosed with hypercholesterolaemia and. Location: JAPAN , 61 years of age, After Livalo was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, rheumatoid factor increased. During the same period patient was treated with NARCARICIN (View Narcaricin Review and Narcaricin Label ), POTOREND (View Potorend Review and Potorend Label ), METOLATE (View Metolate Review and Metolate Label ), MEDROL (View Medrol Review and Medrol Label ), NEUER (View Neuer Review and Neuer Label ).

6905940-7 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Myoglobin Blood Increased
on Jul 15, 2010 Female patient from JAPAN , 50 years of age, weighting 114.6 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myoglobin blood increased. Livalo dosage: 2 Mg; 1x; Po, 4 Mg; 1x; Po. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), SG (View Sg Review and Sg Label ), ALLEGRA (View Allegra Review and Allegra Label ).

6896772-7 | Decreased Appetite, Haemoptysis, Lung Neoplasm
on Jul 15, 2010 Male patient from JAPAN , 80 years of age, weighting 130.1 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient had the following side effects: decreased appetite, haemoptysis, lung neoplasm. Livalo dosage: 2 Mg; 1x;po, 1 Mg; 1x;po, 1 Mg Qod;po, 1 Mg;1x Po. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), LASIX (View Lasix Review and Lasix Label ), ARTIST (View Artist Review and Artist Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6896771-5 | Hospitalisation
Patient was taking Livalo (View Usage). After Livalo was administered, patient had the following side effects: hospitalisation on Jul 15, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 143.3 lb, was diagnosed with hypercholesterolaemia and. Livalo dosage: 2 Mg; 1x;po. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), AMARYL (View Amaryl Review and Amaryl Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

6896663-1 | Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Creatine Phosphokinase Mb, Blood Lactate Dehydrogenase Increased, Brain Natriuretic Peptide Increased, Cardiac Failure, Discomfort, Pulmonary Oedema, Respiratory Disorder
Adverse event was reported on Jul 22, 2010 by a Male patient taking Livalo (View Usage) (Dosage: 2 Mg; 1x; Po) was diagnosed with dyslipidaemia and. Location: JAPAN , 60 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood albumin decreased, blood creatine phosphokinase mb, blood lactate dehydrogenase increased, brain natriuretic peptide increased, cardiac failure, discomfort, pulmonary oedema, respiratory disorder. During the same period patient was treated with MEDET (CON.) (View Medet (con.) Review and Medet (con.) Label ), GLUTAMEAL (CON.) (View Glutameal (con.) Review and Glutameal (con.) Label ), METHYCOBAL /00324901/ (CON.) (View Methycobal /00324901/ (con.) Review and Methycobal /00324901/ (con.) Label ), PREMINENT (CON.) (View Preminent (con.) Review and Preminent (con.) Label ), ATELEC (CON.) (View Atelec (con.) Review and Atelec (con.) Label ), BAYASPIRIN (CON.) (View Bayaspirin (con.) Review and Bayaspirin (con.) Label ), PARIET (CON.) (View Pariet (con.) Review and Pariet (con.) Label ), KAKKON TO (CON.) (View Kakkon-to (con.) Review and Kakkon-to (con.) Label ). Patient was hospitalized.

6896662-X | Amyotrophic Lateral Sclerosis
on Jul 22, 2010 Female patient from JAPAN , 69 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). Livalo dosage: 1 Mg; 1x; Po. During the same period patient was treated with TENORMIN (CON.) (View Tenormin (con.) Review and Tenormin (con.) Label ), ADALAT CR (CON.) (View Adalat Cr (con.) Review and Adalat Cr (con.) Label ).

6896661-8 | Lymphoma
on Jul 15, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: lymphoma (What is lymphoma?). Livalo dosage: 1x; Po, Mg; 1x; Po.

6895730-6 | Myocardial Infarction
Patient was taking Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Jul 20, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 169.8 lb, was diagnosed with dyslipidaemia and. Livalo dosage: 2 Mg; 1x; Po. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), HYDROCHLORIDE (View Hydrochloride Review and Hydrochloride Label ), LORCET HD (View Lorcet-hd Review and Lorcet-hd Label ), PHENERGAN (View Phenergan Review and Phenergan Label ).

6862632-0 | Community Acquired Infection, Interstitial Lung Disease, Lymphocyte Stimulation Test Positive, Pneumonia Mycoplasmal, Pruritus, Rash
Adverse event was reported on Jul 07, 2010 by a Female patient taking Livalo (View Usage) (Dosage: 1 Mg; 1x; Po) was diagnosed with hyperlipidaemia, pneumonia mycoplasmal and. Location: JAPAN , 83 years of age, weighting 117.9 lb, Patient had the following side effects: community acquired infection, interstitial lung disease, lymphocyte stimulation test positive, pneumonia mycoplasmal, pruritus, rash (What is rash?). During the same period patient was treated with MINOPEN (MINOCYCLINE HYDROCHLORIDE) (100 Mg; Bid; Ivdrp) (View Minopen (minocycline Hydrochloride) Review and Minopen (minocycline Hydrochloride) Label ), KLARICID (View Klaricid Review and Klaricid Label ), NORVASC (View Norvasc Review and Norvasc Label ), DIOVAN /01319601/ (View Diovan /01319601/ Review and Diovan /01319601/ Label ), METHYCOBAL /00324901/ (View Methycobal /00324901/ Review and Methycobal /00324901/ Label ), FOSAMAC (View Fosamac Review and Fosamac Label ), CLINORIL (View Clinoril Review and Clinoril Label ), DEPAS (View Depas Review and Depas Label ). Patient was hospitalized.

6862630-7 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Mb Abnormal, Myoglobin Blood Increased
on Jun 30, 2010 Female patient from JAPAN , 50 years of age, weighting 114.6 lb, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood creatine phosphokinase mb abnormal, myoglobin blood increased. Livalo dosage: 4 Mg; 1x; Po. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), SG (View Sg Review and Sg Label ), ALLEGRA /01314202/ (View Allegra /01314202/ Review and Allegra /01314202/ Label ).

6862626-5 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Cardiac Failure, Pulmonary Oedema, Respiratory Disorder
on Jul 02, 2010 Male patient from JAPAN , 60 years of age, weighting 165.3 lb, was diagnosed with dyslipidaemia and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, cardiac failure, pulmonary oedema, respiratory disorder. Livalo dosage: 2 Mg; 1x; Po. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLUTAMEAL (View Glutameal Review and Glutameal Label ), METHYCOBAL /00324901/ (View Methycobal /00324901/ Review and Methycobal /00324901/ Label ), LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), ATELEC (View Atelec Review and Atelec Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), KAKKON TO (View Kakkon-to Review and Kakkon-to Label ). Patient was hospitalized.

6786888-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Blood Triglycerides Increased, Malaise, Vomiting
Patient was taking Livalo (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood triglycerides increased, malaise, vomiting on Jun 11, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with hypercholesterolaemia and. Livalo dosage: 1mg Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), GLYCYRRHIZIC ACID (View Glycyrrhizic Acid Review and Glycyrrhizic Acid Label ). Patient was hospitalized.

6780896-9 | Blood Creatine Phosphokinase Increased, Myalgia, Pyrexia
Adverse event was reported on Jun 03, 2010 by a Male patient taking Livalo (View Usage) (Dosage: 1mg, Po) . Location: JAPAN , 88 years of age, After Livalo was administered, patient had the following side effects: blood creatine phosphokinase increased, myalgia, pyrexia. During the same period patient was treated with OMEPRAZOLE (10 Mg, Po) (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.

6780895-7 | Abdominal Pain, Back Pain, Rhabdomyolysis
on Jun 03, 2010 Female patient from JAPAN , 50 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), rhabdomyolysis. Livalo dosage: 4 Mg, Po. During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ).

6759680-8 | Vertigo
on May 27, 2010 Male patient from JAPAN , 71 years of age, was treated with Livalo (View Usage). Patient had the following side effects: vertigo. Livalo dosage: . During the same period patient was treated with PITAVASTATIN CALCIUM (View Pitavastatin Calcium Review and Pitavastatin Calcium Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ). Patient was hospitalized.

6758200-1 | Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Malaise, Vomiting
Patient was taking Livalo (View Usage). After Livalo was administered, patient had the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, malaise, vomiting on May 21, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with hypercholesterolaemia and. Livalo dosage: 1mg Po. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), GLYCYRRHIZIC ACID (View Glycyrrhizic Acid Review and Glycyrrhizic Acid Label ). Patient was hospitalized.

6758194-9 | Amyotrophic Lateral Sclerosis
Adverse event was reported on May 20, 2010 by a Female patient taking Livalo (View Usage) (Dosage: 1mg Po) was diagnosed with hypercholesterolaemia and. Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

6755275-0 | Femoral Neck Fracture
on May 20, 2010 Female patient from JAPAN , 70 years of age, was treated with Livalo (View Usage). Patient had the following side effects: femoral neck fracture. Livalo dosage: . During the same period patient was treated with PITAVASTATIN (View Pitavastatin Review and Pitavastatin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ).

6754222-5 | Alanine Aminotransferase Increased, Aortitis, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Coronary Artery Stenosis, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
on May 24, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with dyslipidaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: alanine aminotransferase increased, aortitis, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, coronary artery stenosis, gamma-glutamyltransferase increased, hepatic function abnormal. Livalo dosage: 1mg, Po. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ). Patient was hospitalized.

6719635-6 | Blood Creatine Phosphokinase Increased, Myalgia, Pyrexia
Patient was taking Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, myalgia, pyrexia on Apr 27, 2010 from JAPAN Additional patient health information: Male patient , 88 years of age, . Livalo dosage: 1mg Po. During the same period patient was treated with OMEPRAZOLE (10mg Po) (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.

6376081-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hypercholesterolaemia, Liver Disorder, Malaise, Productive Cough
Adverse event was reported on Sep 08, 2009 by a Female patient taking Livalo (View Usage) (Dosage: 1 Mg, Po) was diagnosed with hypercholesterolaemia and. Location: JAPAN , 61 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hypercholesterolaemia, liver disorder, malaise, productive cough. During the same period patient was treated with FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), CLOPERASTINE FENDIZOATE (View Cloperastine Fendizoate Review and Cloperastine Fendizoate Label ).

6376077-3 | Arthralgia, Dry Skin, Malaise
on Sep 08, 2009 Female patient from JAPAN , 56 years of age, was diagnosed with hypercholesterolaemia and was treated with Livalo (View Usage). After Livalo was administered, patient had the following side effects: arthralgia, dry skin, malaise. Livalo dosage: 1mg Po.

6235240-2 | Hepatic Function Abnormal, Thrombosis In Device
on Jun 16, 2009 Male patient from JAPAN , weighting 143.3 lb, was diagnosed with hyperlipidaemia, hypertension, prophylaxis, acute myocardial infarction, percutaneous coronary intervention, stent placement and was treated with Livalo (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, thrombosis in device. Livalo dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), OMEPRAL (View Omepral Review and Omepral Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (300 Mg Once Followed By 75 Mg) (View Plavix Review and Plavix Label ).

5347304-6 | Cerebellar Infarction, Decreased Appetite, Dizziness, Vomiting
Patient was taking Livalo (View Usage). Patient had the following side effects: cerebellar infarction, decreased appetite, dizziness (What is dizziness?), vomiting on May 24, 2007 from JAPAN Additional patient health information: Female patient , 86 years of age, was diagnosed with hypercholesterolaemia and. Livalo dosage: 1 Mg Day. During the same period patient was treated with DIOVAN (80 Mg, Unk) (View Diovan Review and Diovan Label ). Patient was hospitalized.